Cite
HARVARD Citation
George, S. et al. (n.d.). 1603OInitial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens. Annals of oncology. p. . [Online].